Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
ACS Omega|January 8, 2019
Pharmacophore Modeling, Synthesis, and Antibacterial Evaluation of Chalcones and DerivativesMingming Zhang, Allan M Prior, Marcus M Maddox, et al.Bioorganic & Medicinal Chemistry|August 16, 2011
The structure-activity relationship of urea derivatives as anti-tuberculosis agentsJoshua R Brown, Elton J North, Julian G Hurdle, et al.Iscience|June 13, 2025
Targeting G9a-m<sup>6</sup>A translational mechanism of SARS-CoV-2 pathogenesis for multifaceted therapeutics of COVID-19 and its sequalaeAdil Muneer, Ling Xie, Xuping Xie, et al.Journal of Medicinal Chemistry|September 3, 2015
Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human GliomaGabriella Miklossy, Ui Joung Youn, Peibin Yue, et al.Journal of Medicinal Chemistry|September 20, 2014
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivativesLi Feng, Marcus M Maddox, Md Zahidul Alam, et al.Oncogenesis|July 12, 2025
Ketone drink enhances therapeutic efficacy in prostate cancer by targeting EZH2Chaehyun Yum, Richard A Schaefer, Rui Wang, et al.Nature Cell Biology|February 25, 2022
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesisJun Wang, Xufen Yu, Weida Gong, et al.Cancer Discovery|July 24, 2021
AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway-Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase BJia Xu, Xufen Yu, Tiphaine C Martin, et al.Science Translational Medicine|September 29, 2021
A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse modelsXufen Yu, Dongxu Li, Jithesh Kottur, et al.ACS Pharmacology & Translational Science|October 16, 2025
A First-in-Class Chemical-Induced Proximity System Achieves Dose-Dependent Control of Tumor Protein P53 Gene Activation in Preclinical Models of Gastric CancerTravis J Nelson, Ryan M Kemper, Anna M Chiarella, et al.Pageof 10